Results 141 to 150 of about 202,126 (199)

Predictive value of the Naples prognostic score for no-reflow phenomenon after saphenous vein graft stenting. [PDF]

Biomark Med
Yılmaz C, Karaduman A, Tiryaki MM, Güvendi Şengör B, Unkun T, Kültürsay B, Zehir R.   +6 more
europepmc   +1 more source

Pathological roles of mitochondrial dysfunction in endothelial cells during the cerebral no-reflow phenomenon: A review. [PDF]

Medicine (Baltimore)
Luo X, Zhang S, Wang L, Li J.
europepmc   +1 more source

No-Reflow Phenomenon: Is it the End of the Story? [PDF]

Akdeniz Medical Journal, 2015
openaire   +1 more source

Association Between the Serum Uric Acid to Albumin Ratio and the No-Reflow Phenomenon After Percutaneous Coronary Intervention (PCI): A Systematic Review and Meta-Analysis. [PDF]

Cureus
Ozbay MB, Degirmen S, Gullu A, Nriagu BN, Omer M, Özen Y, Yayla C.   +6 more
europepmc   +1 more source

The effect of the systemic immune-inflammatory index on the no-reflow phenomenon in patients undergoing saphenous vein intervention. [PDF]

Postepy Kardiol Interwencyjnej
Cakmak AC, Kocayigit İ, Varım P, Çakmak BS, Can Y, Vatan MB.   +5 more
europepmc   +1 more source

Clinical, laboratory, and procedural predictors of slow flow/no reflow phenomenon after emergency percutaneous coronary interventions in ST-elevated myocardial infarction. [PDF]

Egypt Heart J
Bamarinejad F, Kermani-Alghoraishi M, Soleimani A, Roohafza H, Yazdekhasti S, Azarm M, Bamarinejad A, Sadeghi M.   +7 more
europepmc   +1 more source

Role of Intracoronary Adrenaline in the Treatment of No-Reflow Phenomenon in Patients Undergoing Percutaneous Coronary Intervention. [PDF]

Cureus
Simoni L, Gjana A, Ziu K, Dibra A, Goda A.   +4 more
europepmc   +1 more source

The HALP score predicts no-reflow phenomenon and long-term prognosis in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention. [PDF]

Coron Artery Dis
Liu H, Zhang F, Li Y, Liu L, Song X, Wang J, Dang Y, Qi X.   +7 more
europepmc   +1 more source

The assessment of no-reflow phenomenon incidence in early versus delayed percutaneous coronary intervention following a primary fibrinolysis. [PDF]

ARYA Atheroscler
Amirpour A, Behjati MA, Zavar R, Shirvani E, Zarepour E, Hassannejad R, Sadeghi M, Janghorbanian Poodeh R, Safaei A, Sanaei S, Parvar NM.   +10 more
europepmc   +1 more source

Predictive value of the triglyceride-glucose index for no-reflow phenomenon after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction complicated by metabolic syndrome. [PDF]

Am J Transl Res
Qu Z, Guan X.
europepmc   +1 more source